Ovation Pharma buys Huntington's disease drug

(Crain’s) — Ovation Pharmaceuticals Inc. said Wednesday it has acquired the rights to a medication that treats the nervous system disorder Huntington’s disease, a move the Deerfield firm called one of its largest deals. Privately held Ovation paid Washington, D.C.-based Prestwick ...

Copyright CRAIN - Crain's
Exit mobile version